Preferred Language
Articles
/
jcoeduw-838
الموقف الأوربي من الملف النووي الإیراني (ألمانیا أنموذجا)

The research tries to discuss the European attitude towards the Iranian nuclear
activities withen its ambitious nuclear program. It studies the European endeavor to settle
this problem peacefully or to solve it by exerting economic and diplomatic pressures on the
Iranian leadership so, it will give up its nuclear ambitions.
Germany exerts single efforts and others withen the European Troika to follow up
the Iranian nuclear case attempting to prevent Iran from acquiring nuclear weapon which
gives Iran a distinguished regional status. Thus , this situation will lead the current regional
equivalence become unbalanced as well as it is conducive to dangerous consequences , to
endanger the security of Israel is the most important one.
Germany endeavors to increase its economic and commercial interests in Iran to
ensure its presence singly or withen the framework of European Troika in the region in a
way that will enhance its role and that of the European Union.
In fact, Germany aims to play an active and influential role in addressing international
events.
In spite of its efforts that aim to appeasement in dealing with the Iranian nuclear
dossier through dialogue or negotiation .
Its attitude will be unaccepted if the doubts concerning Iranian intentions and having
capability to produce nuclear weapon in a way that will endanger Israel security will be
ensured. In this case Germany will support the western attitude that refuses the Iranian
ambitions.

View Publication Preview PDF
Quick Preview PDF
Publication Date
Thu Jun 30 2022
Journal Name
International Journal Of Drug Delivery Technology
. Preparation and Characterization of Atorvastatin Calcium Trihydrate-cyclodextrin Inclusion Complex

Atorvastatin calcium (ATR) is an antihyperlipidemic agent used for lowering blood cholesterol levels. However, it is very slightly soluble in water with poor oral bioavailability, which interferes with its therapeutic action. It is classified as a class II drug according to Biopharmaceutical Classification System (low solubility and high permeability).

View Publication Preview PDF
Scopus (2)
Scopus Crossref